| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 366037O6O7 |
| InChI Key | DSLPMJSGSBLWRE-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C14H15NO5S |
| Molecular Weight | 309.34 |
| AlogP | 1.64 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 2.0 |
| Polar Surface Area | 99.6 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 21.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Steryl-sulfatase inhibitor | PubMed |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Cytochrome P450
Cytochrome P450 family 19
Cytochrome P450 family 19A
Cytochrome P450 19A1
|
- | 300-300 | - | - | - | |
|
Enzyme
Hydrolase
|
- | 2-2600 | - | - | 50-100 | |
|
Enzyme
Lyase
|
- | 17 | - | 1050 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Endometrial Neoplasms | 2 | D016889 | ClinicalTrials |
| Prostatic Neoplasms, Castration-Resistant | 1 | D064129 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 288628-05-7 |
| ChEMBL | CHEMBL286738 |
| DrugBank | DB02292 |
| EPA CompTox | DTXSID50183059 |
| FDA SRS | 366037O6O7 |
| PDB | 667 |
| PubChem | 5287541 |
| SureChEMBL | SCHEMBL1275983 |
| ZINC | ZINC000001549366 |